微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 2.25% | -17.28% | 85.95% | 80/157 | 1.37% | 泽璟制药 | 44.02% | 行业排名> |
| 2026-03-31 | 1.21% | -32.02% | -67.73% | 82/157 | 0.06% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-12-31 | 3.75% | 30.21% | -15.54% | 71/157 | -4.46% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-09-30 | 4.44% | 4.23% | 63.24% | 67/157 | 1.31% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 2.72% | 29.52% | 52.81% | 67/157 | 0.3% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 1.78% | 3.49% | -38.19% | 61/157 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 2.88% | 146.98% | -32.39% | 79/157 | -9.62% | 百利天恒药业 | 181.27% | 行业排名> |
| 2024-09-30 | 4.26% | 161.35% | 102.86% | 70/157 | 4.28% | 百利天恒药业 | 186.1% | 行业排名> |
| 2024-06-30 | 2.1% | 101.92% | 22.09% | 80/157 | 2.69% | 百利天恒药业 | 186.89% | 行业排名> |
| 2024-03-31 | 1.72% | 135.62% | 128.06% | 69/157 | 2.35% | 百利天恒药业 | 188.56% | 行业排名> |
| 2023-12-31 | -6.13% | -773.63% | -476.07% | 119/157 | -1% | 上海小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 1.63% | -30.34% | 56.73% | 105/157 | 2.36% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 1.04% | -14.75% | 42.47% | 103/157 | 1.48% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 0.73% | -48.23% | -19.78% | 100/157 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 0.91% | -65% | -61.11% | 101/157 | 0.79% | 上海小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 2.34% | -30.97% | 91.8% | 92/157 | 2.86% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 1.22% | -43.52% | -13.48% | 101/157 | 2.21% | 上海小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 1.41% | -9.03% | -45.77% | 72/157 | 1.59% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 2.6% | -75.95% | -23.3% | 94/157 | 0.84% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 3.39% | -70.42% | 56.94% | 91/157 | 4.46% | 上海小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 2.16% | -75.76% | 39.35% | 94/157 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 1.55% | -63.27% | -85.66% | 75/157 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 10.81% | -2.35% | -5.67% | 47/157 | 3.8% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 11.46% | 7% | 28.62% | 29/157 | 3.13% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 8.91% | 40.76% | 111.14% | 25/157 | 4.28% | 中哲精化 | 45.32% | 行业排名> |
| 2020-03-31 | 4.22% | 91.82% | -61.88% | 19/157 | 2.23% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 11.07% | 0.82% | 3.36% | 51/157 | 2.57% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 10.71% | 1.13% | 69.19% | 29/157 | 7.58% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 6.33% | -18.74% | 187.73% | 35/157 | 5.02% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 2.2% | -55.1% | -79.96% | 53/157 | 2.45% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 10.98% | -59% | 3.68% | 45/157 | 7.16% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 10.59% | -50.54% | 35.94% | 22/157 | 7.21% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 7.79% | -32.26% | 58.98% | 17/157 | 4.63% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 4.9% | -10.91% | -81.7% | 10/157 | 2.57% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 26.78% | 20.96% | 25.08% | 5/157 | 9.62% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 21.41% | 23.97% | 86.17% | 4/157 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 11.5% | -4.25% | 109.09% | 10/157 | 5.56% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 5.5% | 17.77% | -75.16% | 6/157 | 2.1% | 中哲精化 | 54.24% | 行业排名> |
| 2016-12-31 | 22.14% | 101.82% | 28.2% | 16/157 | 6.05% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 17.27% | 58.44% | 43.8% | 9/157 | 5.64% | ST南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 12.01% | 83.36% | 157.17% | 7/157 | 3.52% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 4.67% | 43.69% | -57.43% | 14/157 | 2.69% | 贝达药业 | 16.78% | 行业排名> |